Colgate-Palmolive (NYSE:CL) Shares Sold by Newfound Research LLC

Newfound Research LLC reduced its position in Colgate-Palmolive (NYSE:CLGet Rating) by 32.1% in the 2nd quarter, Holdings Channel reports. The firm owned 1,118 shares of the company’s stock after selling 528 shares during the quarter. Newfound Research LLC’s holdings in Colgate-Palmolive were worth $90,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in CL. Core Alternative Capital increased its stake in shares of Colgate-Palmolive by 924.3% in the 1st quarter. Core Alternative Capital now owns 379 shares of the company’s stock worth $29,000 after acquiring an additional 342 shares during the last quarter. Carl Stuart Investment Advisor Inc. acquired a new stake in shares of Colgate-Palmolive in the 1st quarter worth $30,000. Riverview Trust Co acquired a new stake in shares of Colgate-Palmolive in the 1st quarter worth $38,000. US Asset Management LLC acquired a new stake in shares of Colgate-Palmolive in the 1st quarter worth $39,000. Finally, Operose Advisors LLC increased its stake in shares of Colgate-Palmolive by 340.7% in the 1st quarter. Operose Advisors LLC now owns 595 shares of the company’s stock worth $45,000 after acquiring an additional 460 shares during the last quarter. 78.62% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on the company. StockNews.com downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Monday. Deutsche Bank Aktiengesellschaft cut their price objective on Colgate-Palmolive from $88.00 to $87.00 in a research report on Tuesday, July 19th. Wells Fargo & Company raised Colgate-Palmolive to an “equal weight” rating in a research report on Tuesday, August 9th. UBS Group raised their price objective on Colgate-Palmolive from $88.00 to $90.00 and gave the stock a “buy” rating in a research report on Monday, August 1st. Finally, JPMorgan Chase & Co. cut their price objective on Colgate-Palmolive from $79.00 to $78.00 in a research report on Thursday, July 21st. Thirteen equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, Colgate-Palmolive presently has an average rating of “Hold” and an average target price of $84.57.

Colgate-Palmolive Stock Down 0.3 %

Shares of CL traded down $0.21 during midday trading on Friday, hitting $75.15. The company had a trading volume of 218,551 shares, compared to its average volume of 4,156,094. The company’s 50-day simple moving average is $78.86 and its 200-day simple moving average is $78.05. The company has a debt-to-equity ratio of 14.26, a quick ratio of 0.72 and a current ratio of 1.17. The firm has a market capitalization of $62.68 billion, a P/E ratio of 32.55, a P/E/G ratio of 5.36 and a beta of 0.48. Colgate-Palmolive has a 1 year low of $72.20 and a 1 year high of $85.61.

Colgate-Palmolive (NYSE:CLGet Rating) last posted its earnings results on Friday, July 29th. The company reported $0.72 earnings per share for the quarter, topping the consensus estimate of $0.71 by $0.01. The firm had revenue of $4.48 billion during the quarter, compared to analysts’ expectations of $4.35 billion. Colgate-Palmolive had a return on equity of 315.10% and a net margin of 10.98%. The firm’s revenue was up 5.3% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.80 earnings per share. As a group, sell-side analysts expect that Colgate-Palmolive will post 3.03 EPS for the current year.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, November 15th. Investors of record on Friday, October 21st will be paid a dividend of $0.47 per share. This represents a $1.88 annualized dividend and a yield of 2.50%. The ex-dividend date of this dividend is Thursday, October 20th. Colgate-Palmolive’s payout ratio is 81.39%.

Insider Buying and Selling

In related news, insider Sally Massey sold 656 shares of the business’s stock in a transaction that occurred on Tuesday, September 13th. The stock was sold at an average price of $77.58, for a total transaction of $50,892.48. Following the completion of the sale, the insider now owns 7,913 shares in the company, valued at $613,890.54. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. In other Colgate-Palmolive news, CEO Noel R. Wallace sold 51,665 shares of Colgate-Palmolive stock in a transaction that occurred on Thursday, August 4th. The stock was sold at an average price of $81.27, for a total transaction of $4,198,814.55. Following the transaction, the chief executive officer now owns 221,790 shares of the company’s stock, valued at $18,024,873.30. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, insider Sally Massey sold 656 shares of the business’s stock in a transaction that occurred on Tuesday, September 13th. The shares were sold at an average price of $77.58, for a total value of $50,892.48. Following the completion of the transaction, the insider now directly owns 7,913 shares in the company, valued at approximately $613,890.54. The disclosure for this sale can be found here. Insiders sold a total of 125,802 shares of company stock worth $10,100,532 over the last 90 days. 0.32% of the stock is owned by insiders.

About Colgate-Palmolive

(Get Rating)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Recommended Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLGet Rating).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.